- About BSMO
- Task Forces
- Website sponsors
- Contact us
BSMO Annual Meeting 2020
Scientific Programme – Friday 14 & Saturday 15 February 2020
We wish to invite you to the 22nd Annual Meeting of the BSMO, a unique annual opportunity to gather as a community and exchange ideas and engage in cooperation.
These are exciting but also challenging times for the medical oncologist with quickly evolving treatments and getting treatments in a timely fashion to the right patients.
Abstracts on any topic are welcome and you don’t have to be a junior member, as long as you feel like one. For educational purposes junior members will have priority for oral presentations. Also challenging and educational case reports which relate to new therapies will be considered.
Looking forward to meet you at this exciting meeting on February 14 and 15!
Friday 14 february 2020:
09:30 Registration and Coffee
10:00 Breast cancer task force
12:00 General assembly and lunch
13:30-15:30 News in specific areas
14:30 EORTC real life data
15:30 Coffee break
16:00 Proferred papers by junior members
17:30 Summary and closing
Aperitif and possibility for the different BSMO task forcesto have a discussion corner
18:30 Visit of Gent
19:30 Walking Diner
Saturday 15 february 2020:
08:45 Registration & Coffee
09:15 Hematology for the medical oncologist
10:45 Coffee Break
11:15 Activities of different BSMO task forces
12:15 Keynote lecture or paper of the year
13:00 Junior awards
13:30 Sandwich lunch
Please use this link to register for this meeting.
Call for abstracts
Everybody is encouraged to submit an abstract.
Abstracts on any topic are welcome, and you don’t have to be a junior member, as long as you feel like one.
For educational purposes, junior members will have priority for oral presentations.
Abstract submission deadline: Monday, January 19th, 23:00hrs
Please use the following link to submit the abstract.
New venue location
Cultuur – en Congrescentrum Het Pand
Onderbergen 1, 9000 Gent, België
Interested in becoming a sponsor of the BSMO Annual Meeting 2020, please contact Congress Care || mr. Pepijn Klerkx, via e-mail at: email@example.com
Disclaimer: sponsoring is not used for funding of social and/or entertaining acitivites.
Immune checkpoint inhibitors might be used for organ transplant patients under special very controlled circumstances. Malignancy is a significant adverse …
A platform has been made available in order to process the requests: https://msd-keytruda-hnscc-mnp.atramed.solutions On this website you can register a …